5 Stocks to Buy Under $15 According to Travis Cocke’s Voss Capital

Page 5 of 5

1. Aptose Biosciences Inc. (NASDAQ:APTO)

Voss Capital Stake Value: $1.4 million

Percent of Voss Capital’ Portfolio: 0.58%

 

Stock Price: $2.18

Number of Hedge Fund Holders: 38

Aptose Biosciences Inc. (NASDAQ:APTO) focuses on designing and developing personalized therapies for the oncology sector. The company also produces biotech solutions for genetic diseases. The company is based in Toronto.

At the end of the second quarter of 2021, Voss Capital held 420,161 shares worth $1.395 million in Aptose Biosciences Inc. (NASDAQ:APTO). The fund reduced its holdings by 5% in the second quarter of 2021. These shares account for 0.58% of the hedge fund’s 13F holdings.

OrbiMed Advisors is the leading hedge fund investor in Aptose Biosciences Inc. (NASDAQ:APTO), holding over 8 million shares worth $26.6 million as of the second quarter of 2021.

According to the database of Insider Monkey tracking 873 hedge funds in Q2 2021, 18 funds have stakes in Aptose Biosciences Inc. (NASDAQ:APTO), worth $93.5 million. This number has decreased from 23 in the Q1 of 2021, worth $173 million.

You can also take a peek at 10 Reddit’s WallStreetBets Stocks Under $5 and 10 Best Safe Dividend Stocks According to Billionaire Dan Loeb.

Follow Insider Monkey on Twitter

Page 5 of 5